Ultrasound Guided Femoral Nerve Block

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center
• Treatments: Bupivacaine; Morphine

Criteria

Inclusion Criteria:

• Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score >= 31) at the time of enrollment.

Exclusion Criteria:

• Patients with a previous history of hypersensitivity to local anesthetics,

• Patients who have signs of a local infection at the site of planned needle placement.

• INR > 1.4NOAC use within 48 hours

• Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours

• Therapeutic LMWH within 24 hours

• Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours